Early onset of puberty and early ovarian failure in CYP7B1 knockout mice

Yoko Omoto1, Richard Lathe, Margaret Warner

  • 1Department of Medical Nutrition, Karolinska Institute, 141 86 Huddinge, Sweden.

Insights

The enzyme CYP7B1 regulates estrogenic effects of androgen metabolites. Its absence in mice leads to early reproductive organ development and continuous estrogenic stimulation.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Biochemistry

Background:

  • The enzyme Cytochrome P450 7B1 (CYP7B1) metabolizes androgen metabolites.
  • 5alpha-androstane-3beta, 17beta-diol (3betaAdiol) is an androgen metabolite with estrogenic activity.
  • CYP7B1 regulates the estrogenicity of 3betaAdiol, particularly in cells expressing estrogen receptors (ERalpha or ERbeta).

Purpose of the Study:

  • To investigate the physiological role of CYP7B1 in regulating estrogenic actions.
  • To determine the consequences of CYP7B1 deficiency on reproductive development and function.

Main Methods:

  • Utilized CYP7B1 knockout (CYP7B1-/-) mouse models.
  • Compared reproductive organ development and estrus cyclicity between CYP7B1-/- mice and wild-type littermates.

Main Results:

  • Female CYP7B1-/- mice exhibited precocious growth of the uterus and mammary glands.
  • Estrus cycles initiated 2 days earlier in CYP7B1-/- mice compared to controls.
  • Adult mammary glands and uteri in CYP7B1-/- mice showed signs of continuous estrogenic stimulation.

Conclusions:

  • CYP7B1 plays a critical role in cell-specific regulation of 3betaAdiol's estrogenicity.
  • CYP7B1 enables 3betaAdiol to exert growth-inhibitory effects via ERbeta.
  • CYP7B1 protects specific cells from 3betaAdiol's estrogenic effects, allowing estradiol-specific ER activation.
  • Inactivation of CYP7B1 leads to indiscriminate 3betaAdiol activation of estrogen receptors, resulting in prolonged estrogen exposure.